In vitro activity of moxifloxacin and linezolid against mycobacteriaSource: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Lack of penetration of amikacin into saliva of tuberculosis patients Source: Eur Respir J, 51 (1) 1702024; 10.1183/13993003.02024-2017 Year: 2018
In-vitro comparison of tobramycin nebulised using two different nebuliser systems Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Intracellular accumulation and bactericidal activity of moxifloxacin and ciprofloxacin in primary respiratory epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Comparison of immunomodulating effects among clarithromycin, dexamethasone and levofloxacin on the murine model of mycoplasma pneumoniae pneumonia Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Penetration of newer quinolones in the empyema fluid Source: Eur Respir J 2004; 24: 466-470 Year: 2004
In-vitro and in-vivo activity of rifampicin and rifabutin against multi-drug-resistant strains of mycobacterium tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 567s Year: 2002
Clinical efficacy of arbekacin on MRSA pneumonia by intramuscularly injection Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Pharmacodynamics of moxifloxacin and four macrolides in the absence or presence of macrophages Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis Source: Eur Respir J , 49 (3) 1601724; DOI: 10.1183/13993003.01724-2016 Year: 2017
Comparison of conventional and sequential antibiotic therapy of community-acquired pneumonia with levofloxacin and moxifloxacin Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Pharmacokinetics of instilled versus nebulized tobramycin or Imipenem in mechanically ventilated ICU patients Source: Eur Respir J 2002; 20: Suppl. 38, 16s Year: 2002
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis Source: Eur Respir J 2016; 47: 1229-1234 Year: 2016
Comparison of moxifloxacin and ofloxacin in treatment of multidrug resistant pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Penetration of azithromycin in experimental pleural empyema model fluid Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017
Safety and efficacy of linezolid, clarithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Effectiveness and safety of gatifloxacin in patients with drug resistance tuberculosus befor unsuccessfully treated with ofloxacin and ciprofloxacin Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006
Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin Source: Eur Respir J, 55 (5) 1901903; 10.1183/13993003.01903-2019 Year: 2020
In-vitro deposition study of a levofloxacin (LEV) solution into a novel human nasal cast model by the PARI VibrENTÔSource: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006